Albert Zimmerli Net Worth

The estimated Net Worth of Albert Rene Zimmerli is at least 316 千$ dollars as of 2 September 2021. Mr. Zimmerli owns over 2,500 units of R1 RCM stock worth over 315,879$ and over the last 6 years he sold RCM stock worth over 0$. In addition, he makes 0$ as Director at R1 RCM.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Zimmerli RCM stock SEC Form 4 insiders trading

Albert has made over 3 trades of the R1 RCM stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 2,500 units of RCM stock worth 49,200$ on 2 September 2021.

The largest trade he's ever made was buying 10,000 units of R1 RCM stock on 6 September 2018 worth over 97,300$. On average, Albert trades about 7,457 units every 364 days since 2018. As of 2 September 2021 he still owns at least 22,371 units of R1 RCM stock.

You can see the complete history of Mr. Zimmerli stock trades at the bottom of the page.

Albert Zimmerli biography

Albert Rene Zimmerli serves as Director of the Company. Mr. Zimmerli has been the Chief Financial Officer of Intermountain Healthcare, a not-for-profit health system based in Salt Lake City, Utah, since 2003, serving as senior vice president from 2003 to 2012 and as executive vice president since 2012. Mr. Zimmerli is responsible for the direction and oversight of all Intermountain financial operations, as well as Intermountain’s supply chain and information systems operations and new business development and innovation strategies. Prior to joining Intermountain, Mr. Zimmerli was the executive vice president and chief financial officer of the Methodist Hospital System in Houston, Texas. Prior to that, he served in numerous capacities with Memorial Hermann Healthcare System in Houston, including senior vice president and chief financial officer. He also was a partner in Ernst & Young’s Houston office, where he spent 16 years, specializing in healthcare. Mr. Zimmerli serves on the boards of several privately-held companies. He also has served, and in some cases continues to serve, in an advisory capacity for several private equity funds for which Intermountain is a limited partner. Mr. Zimmerli is the Intermountain Designee.

How old is Albert Zimmerli?

Albert Zimmerli is 68, he's been the Director of R1 RCM since 2018. There are 4 older and 11 younger executives at R1 RCM. The oldest executive at R1 RCM Inc. is Michael Feiner, 77, who is the Independent Director.

What's Albert Zimmerli's mailing address?

Albert's mailing address filed with the SEC is C/O R1 RCM INC., 434 W. ASCENSION WAY, 6TH FLOOR, MURRAY, UT, 84123.

Insiders trading at R1 RCM

Over the last 8 years, insiders at R1 RCM have traded over 770,079,900$ worth of R1 RCM stock and bought 103,238 units worth 1,376,421$ . The most active insiders traders include Achi Series Lllptcp Asc Gp,...、Joseph Gerard Flanagan、John B Iii Henneman. On average, R1 RCM executives and independent directors trade stock every 27 days with the average trade being worth of 7,812,780$. The most recent stock trade was executed by John M. Sparby on 6 March 2024, trading 10,046 units of RCM stock currently worth 143,959$.

What does R1 RCM do?

R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.

Complete history of Mr. Zimmerli stock trades at R1 RCM

R1 RCM executives and stock owners

R1 RCM executives and other stock owners filed with the SEC include:

• Joseph Flanagan,
  President, Chief Executive Officer, Director
• Gary Long,
  Executive Vice President, Chief Commercial Officer
• Joseph Gerard Flanagan,
  Pres, CEO & Director
• Gary S. Long,
  Exec. VP & Chief Commercial Officer
• Richard Evans,
  Senior Vice President, Chief Accounting Officer, Corporate Controller
• Richard B. Evans Jr.,
  Sr. VP, Corp. Controller & Chief Accounting Officer
• Rachel Wilson,
  Exec. VP, CFO & Treasurer
• Alex Mandl,
  Lead Independent Director
• Michael Feiner,
  Independent Director
• Jill Smith,
  Independent Director
• John Henneman,
  Independent Director
• Anthony Tersigni,
  Director
• Anthony Speranzo,
  Independent Director
• Rachel Wilson,
  Chief Financial Officer, Treasurer
• Atif Rahim,
  Senior Vice President - Investor Relations & Business Development
• Vijay Kotte,
  Executive Vice President - Physician Services
• Ian Sacks,
  Independent Director
• Neal Moszkowski,
  Independent Director
• Albert Zimmerli,
  Director
• Vijay Kumar Kotte,
  Exec. VP of Strategy & Corp. Devel. and Chief Solutions Officer
• Sean Radcliffe,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Corey Perman,
  Exec. VP of Compliance & Risk
• Jay Sreedharan,
  Chief Technology & Digital Officer
• John M. Sparby,
  Exec. VP of Operations & Delivery and COO
• Charles J. Ditkoff,
  Director
• Steven J Shulman,
  Director
• Christopher Simon Ricaurte,
  Chief Financial Officer
• Mountain Capital, L.L.C.Coy...,
  
• Pamela L. Spikner,
  Principal Accounting Officer
• Thomas A Lesica,
  Chief Operating Officer
• Bradford Kyle Armbrester,
  Director
• Jeremy Delinsky,
  Director
• David M Dill,
  Director
• Scanlan Agnes Bundy,
  Director
• Lee Rivas,
  Chief Executive Officer
• John M. Sparby,
  President
• Jennifer D. Williams,
  Chief Financial Officer
• Kyle Hicok,
  Chief Commercial Officer